
An antitrust lawsuit filed against Microsoft by a group of gamers last year has now been dismissed by a Judge due to the complaint “not plausibly” alleging anticompetitive effects, reported Reuters.
The ‘Gamers’ Lawsuit’, which was first brought to court in December 2022, was filed by a group of 10 gamers from California, New Mexico, and New Jersey. The consumer antitrust suit was over its $69 billion proposed purchase of “Call of Duty” maker Activision Blizzard. The plaintiffs, however, were given 20 days to refine their legal challenge.
On Tuesday, a federal judge in San Francisco issued an opinion that the plaintiff’s lawsuit challenging the proposed acquisition lacked sufficient evidence to prove their claim of potential harm to competition. The court concluded that the litigation was unsupported by any substantive allegations.
Related: Microsoft Offers Concessions To EU Over Activision Blizzard Deal
“Plaintiffs’ general allegation that the merger may cause ‘higher prices, less innovation, less creativity, less consumer choice, decreased output, and other potential anticompetitive effects’ is insufficient,” wrote US District Judge Jacqueline Corley.
The decision to dismiss the gamer’s suit does not affect the US Federal Trade Commission’s regulatory challenge to this deal. Microsoft announced its bid last year, and it also faces competition scrutiny in the EU and UK. Microsoft has denied the deal would harm video game competition.
Featured News
Federal Court to Hear Case on Trump’s Firing of FTC Democrats
May 20, 2025 by
CPI
UK Government Suffers Third Successive Defeat on Data (Use and Access) Bill
May 20, 2025 by
CPI
Sex Toy Retailer Says Google Breaches EU Digital Market Rules
May 20, 2025 by
CPI
Latham & Watkins Expands Brussels Antitrust Team
May 20, 2025 by
CPI
Brazil’s Antitrust Watchdog Expected to Approve Pet Retail Merger Without Conditions
May 20, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas